Compare ABOS & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABOS | DOMO |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.4M | 171.6M |
| IPO Year | 2021 | 2018 |
| Metric | ABOS | DOMO |
|---|---|---|
| Price | $2.31 | $2.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $8.00 | ★ $10.28 |
| AVG Volume (30 Days) | 353.3K | ★ 2.0M |
| Earning Date | 05-12-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.92 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $318,857,000.00 |
| Revenue This Year | N/A | $3.41 |
| Revenue Next Year | N/A | $4.72 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $1.10 | $1.84 |
| 52 Week High | $3.60 | $18.49 |
| Indicator | ABOS | DOMO |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 36.93 |
| Support Level | $2.14 | $2.39 |
| Resistance Level | $2.42 | $4.07 |
| Average True Range (ATR) | 0.14 | 0.39 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 26.64 | 20.21 |
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.